Baotou Dongbao Bio-TechLtd Balance Sheet Health
Financial Health criteria checks 5/6
Baotou Dongbao Bio-TechLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥474.7M, which brings its debt-to-equity ratio to 27.6%. Its total assets and total liabilities are CN¥2.7B and CN¥996.9M respectively. Baotou Dongbao Bio-TechLtd's EBIT is CN¥99.5M making its interest coverage ratio -22.1. It has cash and short-term investments of CN¥638.8M.
Key information
27.6%
Debt to equity ratio
CN¥474.69m
Debt
| Interest coverage ratio | -22.1x |
| Cash | CN¥638.83m |
| Equity | CN¥1.72b |
| Total liabilities | CN¥996.93m |
| Total assets | CN¥2.72b |
Recent financial health updates
No updates
Recent updates
Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost
Oct 08
We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)
Oct 01Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022
May 27Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)
Feb 28Financial Position Analysis
Short Term Liabilities: 300239's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥442.3M).
Long Term Liabilities: 300239's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥554.6M).
Debt to Equity History and Analysis
Debt Level: 300239 has more cash than its total debt.
Reducing Debt: 300239's debt to equity ratio has increased from 7.1% to 27.6% over the past 5 years.
Debt Coverage: 300239's debt is well covered by operating cash flow (20.7%).
Interest Coverage: 300239 earns more interest than it pays, so coverage of interest payments is not a concern.